Ingeborg Hers

4.7k total citations · 1 hit paper
65 papers, 3.6k citations indexed

About

Ingeborg Hers is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ingeborg Hers has authored 65 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 35 papers in Hematology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ingeborg Hers's work include Platelet Disorders and Treatments (31 papers), PI3K/AKT/mTOR signaling in cancer (16 papers) and Cell Adhesion Molecules Research (12 papers). Ingeborg Hers is often cited by papers focused on Platelet Disorders and Treatments (31 papers), PI3K/AKT/mTOR signaling in cancer (16 papers) and Cell Adhesion Molecules Research (12 papers). Ingeborg Hers collaborates with scholars based in United Kingdom, Canada and United States. Ingeborg Hers's co-authors include Jeremy M. Tavaré, Emma E. Vincent, Roger W. Hunter, Tom N. Durrant, Marion T.J. van den Bosch, Alastair W. Poole, Samantha Moore, Daniel C. Berwick, Kate J. Heesom and S K Moule and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Ingeborg Hers

64 papers receiving 3.5k citations

Hit Papers

Akt signalling in health and disease 2011 2026 2016 2021 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingeborg Hers United Kingdom 28 1.9k 838 450 411 338 65 3.6k
Franck Peiretti France 31 1.5k 0.8× 363 0.4× 326 0.7× 587 1.4× 604 1.8× 82 3.6k
Françoise Bono France 29 1.3k 0.7× 403 0.5× 341 0.8× 404 1.0× 398 1.2× 65 2.7k
William L. Dean United States 29 2.0k 1.0× 404 0.5× 218 0.5× 350 0.9× 191 0.6× 94 3.0k
Carol Dangelmaier United States 33 1.0k 0.5× 1.4k 1.7× 718 1.6× 163 0.4× 448 1.3× 89 3.1k
S Lévy-Toledano France 38 1.5k 0.8× 1.6k 1.9× 660 1.5× 238 0.6× 318 0.9× 135 4.1k
Britta Walker Germany 15 1.1k 0.6× 406 0.5× 433 1.0× 171 0.4× 373 1.1× 21 2.7k
Abdelkarim Sabri United States 36 1.9k 1.0× 297 0.4× 1.4k 3.1× 434 1.1× 266 0.8× 59 3.5k
Richard J. Haslam Canada 37 2.2k 1.1× 917 1.1× 813 1.8× 207 0.5× 269 0.8× 79 4.3k
S E Rittenhouse United States 35 3.3k 1.7× 1.4k 1.7× 803 1.8× 409 1.0× 557 1.6× 54 5.5k
Nisar A. Pampori United States 21 928 0.5× 673 0.8× 187 0.4× 246 0.6× 226 0.7× 37 3.0k

Countries citing papers authored by Ingeborg Hers

Since Specialization
Citations

This map shows the geographic impact of Ingeborg Hers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingeborg Hers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingeborg Hers more than expected).

Fields of papers citing papers by Ingeborg Hers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingeborg Hers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingeborg Hers. The network helps show where Ingeborg Hers may publish in the future.

Co-authorship network of co-authors of Ingeborg Hers

This figure shows the co-authorship network connecting the top 25 collaborators of Ingeborg Hers. A scholar is included among the top collaborators of Ingeborg Hers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingeborg Hers. Ingeborg Hers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutchinson, James L., Michael P. Keith, Robin A. Corey, et al.. (2024). Difluorinated thromboxane A2 reveals crosstalk between platelet activatory and inhibitory pathways by targeting both the TP and IP receptors. British Journal of Pharmacology. 181(19). 3685–3699.
2.
May, Carl, et al.. (2024). PROTACs in platelets: emerging antithrombotic strategies and future perspectives. Current Opinion in Hematology. 32(1). 34–42. 1 indexed citations
3.
Bull, Caroline J., Jie Zheng, Benjamin Elsworth, et al.. (2023). A phenome-wide approach to identify causal risk factors for deep vein thrombosis. BMC Medical Genomics. 16(1). 284–284. 4 indexed citations
4.
Heesom, Kate J., Samantha Moore, Alastair W. Poole, et al.. (2022). Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function. Blood Advances. 7(9). 1692–1696. 5 indexed citations
5.
Corbin, Laura J., Andrew Mumford, Parsa Akbari, et al.. (2022). Higher body mass index raises immature platelet count: potential contribution to obesity-related thrombosis. Platelets. 33(6). 869–878. 13 indexed citations
6.
Agbani, Ejaife O., Ingeborg Hers, & Alastair W. Poole. (2022). Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?. Blood Advances. 7(8). 1615–1619. 6 indexed citations
7.
Moore, Samantha, Ejaife O. Agbani, Alastair W. Poole, et al.. (2021). Opposing Roles of GSK3α and GSK3β Phosphorylation in Platelet Function and Thrombosis. International Journal of Molecular Sciences. 22(19). 10656–10656. 15 indexed citations
8.
Bell, Joshua A., David A. Hughes, Laura J. Corbin, et al.. (2021). Effects of adiposity on the human plasma proteome: observational and Mendelian randomisation estimates. International Journal of Obesity. 45(10). 2221–2229. 26 indexed citations
9.
Agbani, Ejaife O., et al.. (2020). Carbonic Anhydrase Inhibitors suppress platelet procoagulant responses and in vivo thrombosis. Platelets. 31(7). 853–859. 14 indexed citations
10.
Jing, Changcheng, et al.. (2020). Synthesis, Stability, and Biological Studies of Fluorinated Analogues of Thromboxane A2. ACS Central Science. 6(6). 995–1000. 13 indexed citations
11.
Durrant, Tom N. & Ingeborg Hers. (2020). PI3K inhibitors in thrombosis and cardiovascular disease. SHILAP Revista de lepidopterología. 9(1). 8–8. 63 indexed citations
12.
Moore, Samantha, et al.. (2020). Rapamycin restrains platelet procoagulant responses via FKBP-mediated protection of mitochondrial integrity. Biochemical Pharmacology. 177. 113975–113975. 17 indexed citations
13.
Moore, Samantha, et al.. (2019). Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function. Scientific Reports. 9(1). 1468–1468. 12 indexed citations
14.
Durrant, Tom N., James L. Hutchinson, Kate J. Heesom, et al.. (2017). In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function. Blood Advances. 1(14). 918–932. 30 indexed citations
15.
Durrant, Tom N., Ejaife O. Agbani, Kate J. Heesom, et al.. (2016). The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin αIIbβ3 Outside-in Signaling. Journal of Biological Chemistry. 292(5). 1691–1704. 37 indexed citations
16.
Moore, Samantha, Christopher Williams, Edward M. Brown, et al.. (2015). Loss of the insulin receptor in murine megakaryocytes/platelets causes thrombocytosis and alterations in IGF signalling. Cardiovascular Research. 107(1). 9–19. 43 indexed citations
17.
Blair, Thomas A., Samantha Moore, Christopher M. Williams, et al.. (2014). Phosphoinositide 3-Kinases p110α and p110β Have Differential Roles in Insulin-Like Growth Factor-1–Mediated Akt Phosphorylation and Platelet Priming. Arteriosclerosis Thrombosis and Vascular Biology. 34(8). 1681–1688. 35 indexed citations
18.
Moore, Samantha, Marion T.J. van den Bosch, Roger W. Hunter, et al.. (2012). Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)α/β by Protein Kinase C (PKC)α and Akt Promotes Thrombin-mediated Integrin αIIbβ3 Activation and Granule Secretion in Platelets. Journal of Biological Chemistry. 288(6). 3918–3928. 121 indexed citations
19.
Berwick, Daniel C., Ghislaine Dell, Gavin I. Welsh, et al.. (2004). Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles. Journal of Cell Science. 117(25). 5985–5993. 120 indexed citations
20.
Poole, Alastair W., Giordano Pula, Ingeborg Hers, David A. Crosby, & Matthew L. Jones. (2004). PKC-interacting proteins: from function to pharmacology. Trends in Pharmacological Sciences. 25(10). 528–535. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026